Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611544 · ClinicalTrials.gov registry record · NA
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT02611544 is a NA study that has completed, run by Indiana University. The registered enrollment target is 91 participants.
The verdict
NCT02611544, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the recognized prevalence, persistence, and suffering associated with FCR, effective and accessible treatments for FCR are lacking and urgently needed. Our long-term goal is to develop, evaluate, and implement effective behavioral interventions for cancer survivors suffering with FCR.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Survivorship Education
- BEHAVIORAL Acceptance and Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02611544
The ClinicalTrials.gov registry entry for NCT02611544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Enhanced Usual Care is the first listed.
NCT02611544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02611544 about?
NCT02611544 is a clinical study titled "Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors". Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the ...
What is the current status of trial NCT02611544?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2015-12. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT02611544?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Survivorship Education (BEHAVIORAL), Acceptance and Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02611544?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.